November 17, 2026 Uncategorized BetterLife Pharma Announces New Preclinical Research Highlighting Neuroplasticity-Related Effects of Non-Hallucinogenic BETR-001 at Neuroscience 2026 Read More
November 6, 2026 Uncategorized BetterLife Pharma Announces Settlement of Claim with Dr. Steven Sangha Read More
November 5, 2026 Uncategorized BetterLife Pharma Appoints Henry Chow, CPA, CA, to Board of Directors Read More
October 27, 2026 Uncategorized BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm Read More
October 19, 2026 Uncategorized BetterLife Pharma Appoints Professor Richard B. Lipton as Co-Chair of its Scientific Advisory Board Read More
October 15, 2026 Uncategorized BetterLife Pharma Appoints Sheila Leitzinger as Head of Clinical Operations Read More
October 14, 2026 Uncategorized BetterLife Pharma Establishes Scientific Advisory Board for Headache Program; Professor Peter Goadsby Appointed Co-Chair Read More
October 9, 2026 Uncategorized BetterLife Pharma Addresses Notice of Civil Claim Filed by Steven Sangha Read More
September 29, 2026 Uncategorized BetterLife Pharma Announces Rescheduling and Reclassification of Annual General Meeting to Annual General and Special Meeting Read More